About

Gregory is a Senior Associate at the firm whose practice sits at the junction of corporate and commercial advisory and the regulated life-sciences sector. He advises companies active in the production, promotion and distribution of medicinal products on the civil and commercial framework that governs market conduct, distribution and day-to-day operations in healthcare, together with the pharmaceutical-specific regulatory and intellectual-property questions – Including patents, trademarks, data exclusivity and licensing – that shape how those operations are run.

Beyond the life-sciences sector, he maintains an active corporate and commercial practice, advising multinational clients, including Mars Hellas and Dell Technologies Greece, on commercial contracts, distribution arrangements, corporate governance and day-to-day operational legal needs across the FMCG and technology sectors. He has also contributed to legal writing in the life-sciences field, reflecting a sustained engagement with sector-specific regulatory developments. Clients value his structured, analytical approach and his ability to align legal rigour with commercial realities – whether in a regulated pharmaceutical market or in a fast-moving corporate environment.